CELU
CELU
NASDAQ · Biotechnology

Celularity Inc-A

$1.30
+0.13 (+11.11%)
As of Feb 8, 2:20 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 11.07M 10.25M 10.35M
Net Income 2.46M 2.27M 1.98M
EPS
Profit Margin 22.2% 22.1% 19.1%
Rev Growth +5.9% +24.9% +1.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 11.06M 12.27M 11.63M
Total Equity 12.79M 14.31M 15.01M
D/E Ratio 0.86 0.86 0.77
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.48M 3.06M 3.48M
Free Cash Flow 1.46M 1.07M 1.08M